257 related articles for article (PubMed ID: 20018893)
1. MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation.
Meng J; Lien E; Golenbock DT
J Biol Chem; 2010 Mar; 285(12):8695-702. PubMed ID: 20018893
[TBL] [Abstract][Full Text] [Related]
2. MD-2 residues tyrosine 42, arginine 69, aspartic acid 122, and leucine 125 provide species specificity for lipid IVA.
Meng J; Drolet JR; Monks BG; Golenbock DT
J Biol Chem; 2010 Sep; 285(36):27935-43. PubMed ID: 20592019
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2.
Ohto U; Fukase K; Miyake K; Shimizu T
Proc Natl Acad Sci U S A; 2012 May; 109(19):7421-6. PubMed ID: 22532668
[TBL] [Abstract][Full Text] [Related]
4. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
Front Immunol; 2021; 12():631797. PubMed ID: 33815382
[TBL] [Abstract][Full Text] [Related]
5. Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.
Maeshima N; Evans-Atkinson T; Hajjar AM; Fernandez RC
J Biol Chem; 2015 May; 290(21):13440-53. PubMed ID: 25837248
[TBL] [Abstract][Full Text] [Related]
6. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.
Park BS; Song DH; Kim HM; Choi BS; Lee H; Lee JO
Nature; 2009 Apr; 458(7242):1191-5. PubMed ID: 19252480
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide expression profiling and mutagenesis studies reveal that lipopolysaccharide responsiveness appears to be absolutely dependent on TLR4 and MD-2 expression and is dependent upon intermolecular ionic interactions.
Meng J; Gong M; Björkbacka H; Golenbock DT
J Immunol; 2011 Oct; 187(7):3683-93. PubMed ID: 21865549
[TBL] [Abstract][Full Text] [Related]
8. Activation of Human Toll-like Receptor 4 (TLR4)·Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia.
Di Lorenzo F; Kubik Ł; Oblak A; Lorè NI; Cigana C; Lanzetta R; Parrilli M; Hamad MA; De Soyza A; Silipo A; Jerala R; Bragonzi A; Valvano MA; Martín-Santamaría S; Molinaro A
J Biol Chem; 2015 Aug; 290(35):21305-19. PubMed ID: 26160169
[TBL] [Abstract][Full Text] [Related]
9. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
[TBL] [Abstract][Full Text] [Related]
10. Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin.
Resman N; Vasl J; Oblak A; Pristovsek P; Gioannini TL; Weiss JP; Jerala R
J Biol Chem; 2009 May; 284(22):15052-60. PubMed ID: 19321453
[TBL] [Abstract][Full Text] [Related]
11. Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.
Mattis DM; Chervin AS; Ranoa DR; Kelley SL; Tapping RI; Kranz DM
Mol Immunol; 2015 Dec; 68(2 Pt A):203-12. PubMed ID: 26320630
[TBL] [Abstract][Full Text] [Related]
12. Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A.
Yamakawa N; Ohto U; Akashi-Takamura S; Takahashi K; Saitoh S; Tanimura N; Suganami T; Ogawa Y; Shibata T; Shimizu T; Miyake K
Int Immunol; 2013 Jan; 25(1):45-52. PubMed ID: 22962435
[TBL] [Abstract][Full Text] [Related]
13. Tetraacylated lipid A and paclitaxel-selective activation of TLR4/MD-2 conferred through hydrophobic interactions.
Resman N; Oblak A; Gioannini TL; Weiss JP; Jerala R
J Immunol; 2014 Feb; 192(4):1887-95. PubMed ID: 24420921
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel binding to human and murine MD-2.
Zimmer SM; Liu J; Clayton JL; Stephens DS; Snyder JP
J Biol Chem; 2008 Oct; 283(41):27916-27926. PubMed ID: 18650420
[TBL] [Abstract][Full Text] [Related]
16. Critical residues involved in Toll-like receptor 4 activation by cationic lipid nanocarriers are not located at the lipopolysaccharide-binding interface.
Lonez C; Irvine KL; Pizzuto M; Schmidt BI; Gay NJ; Ruysschaert JM; Gangloff M; Bryant CE
Cell Mol Life Sci; 2015 Oct; 72(20):3971-82. PubMed ID: 25956320
[TBL] [Abstract][Full Text] [Related]
17. Structural regions of MD-2 that determine the agonist-antagonist activity of lipid IVa.
Muroi M; Tanamoto K
J Biol Chem; 2006 Mar; 281(9):5484-91. PubMed ID: 16407172
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
Mishra V; Pathak C
J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
[TBL] [Abstract][Full Text] [Related]
19. Identification of key residues that confer Rhodobacter sphaeroides LPS activity at horse TLR4/MD-2.
Irvine KL; Gangloff M; Walsh CM; Spring DR; Gay NJ; Bryant CE
PLoS One; 2014; 9(5):e98776. PubMed ID: 24879320
[TBL] [Abstract][Full Text] [Related]
20. Unique properties of the chicken TLR4/MD-2 complex: selective lipopolysaccharide activation of the MyD88-dependent pathway.
Keestra AM; van Putten JP
J Immunol; 2008 Sep; 181(6):4354-62. PubMed ID: 18768894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
